Clinical Trials in Seattle

Showing 1021-1040 of 4,491 trials

Nonalcoholic Fatty Liver Disease (NAFLD) Database 3

NCT04454463

The NAFLD Database 3 will enroll approximately 1500 adult patients and 750 pediatric patients suspected or known to have NAFLD or NASH-related cirrhosis. To elucidate, through the cooperative effort of a multidisciplinary and multicenter group of collaborators, the etiology, natural history, diagnosis, treatment, and prevention of NAFLD, and in particular its more severe form of NASH and its complications.

Liver Diseases

Johns Hopkins Bloomberg School of Public Health1,649 participantsStarted Nov 2020

La Jolla, California, United States • Los Angeles, California, United States • San Diego, California, United States +13 more locations

Active Not RecruitingNA< 1 mile

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

NCT05478304

This trial is a prospective, randomized, multicenter, multinational, blinded, superiority trial. The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic arterial embolism in subjects undergoing cardiac surgery who have risk factors for atrial fibrillation and ischemic stroke.

Ischemic StrokeSystemic Embolism

AtriCure, Inc.6,573 participantsStarted Jan 2023

Huntsville, Alabama, United States • Scottsdale, Arizona, United States • Jonesboro, Arkansas, United States +140 more locations

Nonalcoholic Fatty Liver Disease (NAFLD) Database 3

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

Find Trials by Condition in Seattle

Efficacy of Virtual Warrior Renew Therapy for Veterans Who Experienced Military Sexual Trauma

MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas

A Study of GC012F (AZD0120), a CAR T Therapy Targeting CD19 and BCMA in Subjects With Relapsed/Refractory Multiple Myeloma

An Initial Study of the Implementation of Digital Therapeutics for Substance Use Disorders in Primary Care

A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis

Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin Lymphoma

Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

Connect® MM- The Multiple Myeloma Disease Registry

A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy

A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)

A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer

Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer

To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa

A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors